| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2077402 | Cell Stem Cell | 2015 | 4 Pages |
Abstract
A new system for conditional approval of regenerative medicine products will allow products of undetermined efficacy to enter the Japanese market. The potential scientific, economic, and ethical implications of this program highlight the need for further discussion and refinement.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Douglas Sipp,